Global Antipsychotic Drugs Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Antipsychotic Drugs Market was valued at $19.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.4% CAGR, to an estimated market size of $26.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global antipsychotic drugs market encompasses pharmaceutical agents used to manage psychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These medications, categorized into first, second, and third-generation classes, primarily function by modulating neurotransmitter pathways like dopamine and serotonin to alleviate symptoms such as hallucinations and delusions.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Antipsychotic Drugs Market in the period 2025-30:
- The market is seeing a rapid shift toward Long-Acting Injectables (LAIs) to enhance patient compliance and minimize the risk of relapse.
- Development of Third-Generation antipsychotics is accelerating as they offer improved safety profiles and fewer extrapyramidal side effects.
- Innovation is moving toward non-dopaminergic mechanisms, such as muscarinic receptor agonists, to address cognitive symptoms of schizophrenia.
- Digital health integration, including AI-driven diagnostics and wearable monitoring, is becoming a standard adjunct to pharmacological treatment.
- Growing global awareness and the destigmatization of mental health are driving higher diagnosis rates and treatment seeking behavior.
- Pharmaceutical companies are increasingly utilizing precision psychiatry and biomarkers to tailor antipsychotic treatments to individual patient profiles.
- The market faces challenges from patent expirations of major atypical drugs, leading to increased availability of low-cost generic alternatives.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Second-Generation (Atypical)
- First-Generation (Typical)
- Third-Generation